All Q3 FY26 results →
Y

Yasho Industries Ltd

Q3 FY26Chemicals & Petrochemicals

Yasho Industries Q3 FY26 earnings call: Revenue & Margins

Q3 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹4,400
Market cap₹5.0K Cr
P/E95.9
Updated23 Aug 2026
Read4 min read

The short version

Yasho Industries aims to achieve approximately INR 1,500 crores revenue by FY '28 at around 40% utilization of Pakhajan facility capacity. Yasho Industries targets revenue of approx.

From Yasho Industries Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Yasho Industries aims to achieve approximately INR 1,500 crores revenue by FY '28 at around 40% utilization of Pakhajan facility capacity.
  • Revenue potential of INR 1,500 crores by FY '28 reflects the company's capacity after debottlenecking and long-term supply agreements.
  • Expected optimal utilization of 80-85% at Pakhajan plant by FY '28, with associated revenue between INR 750-850 crores depending on market conditions.
  • Growth will be supported by increased capacity utilization, new long-term contracts, and geographic diversification (Europe, Americas, Africa, Asia).
  • The company anticipates 15-25% annual growth over the long term, supported by existing infrastructure.
  • Domestic markets show strong growth driven by industrial and consumer segments, enabled by aggressive pricing and expanded customer reach.

2 more points from Yasho Industries Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Yasho Industries Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Current year FY '26 capex is around INR 60 crores, including INR 25 crores for two new manufacturing lines and INR 25 crores for R&D.
  • Equipment deliveries for a strategic manufacturing project with a large MNC (cost approx. INR 85-90 crores) funded fully by the customer are expected to begin in Q2 FY '27, with commercialization targeted for Q1 FY '28.
  • Trial runs for the two new manufacturing lines are expected in March 2026, with commercial production planned for Q1 FY '27.
  • Additional planned capex for FY '26 has been deferred, with decisions pending based on market conditions.

2 more points from Yasho Industries Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 2Mar 1
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Yasho Industries Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • Yasho Industries has an outstanding orderbook, with confidence to achieve INR1,500 crores revenue potential by FY '28.
  • For FY '26, the company expects to close around INR800 crores in revenue.
  • Capacity utilization at the Pakhajan plant is expected to reach around 80-85% by FY '28, supporting the revenue target.
  • Long-term supply agreements (LTSAs) are being pursued to secure a majority of capacity utilization (60-70% of sales).
  • Discussions are ongoing with multiple large MNC customers for significant contracts, though specifics remain confidential due to NDAs.

2 more points from Yasho Industries Ltd's call on order book

Pro opens every point from 15K+ earnings calls

Yasho Industries Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹246 Cr, net profit ₹12 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Neochem Bio (Q3 FY26)

    Revenue for Q2 FY26 (Sept’25) stood at ₹4,583.16 Lakh. Key investor presentation takeaways from Neochem Bio Solutions Ltd's Q3 FY26 investor presentation — and

  • Thirumalai Chemicals Ltd (Q3 FY26)

    Q3 FY26 Revenue from Operations (INR Cr):** . Key investor presentation takeaways from Thirumalai Chemicals Ltd's Q3 FY26 investor presentation — and how it ran

  • Gujarat Alkalies (Q3 FY26)

    3,144.48 Crores, down from Rs. Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q3 FY26 investor presentation — and how it ranks agai

  • Jubilant Agri & Consumer Products Ltd (Q3 FY26)

    Q3 FY26 Revenue from Operations: INR 4,510 million, up 13% YoY from INR 3,975 million in Q3 FY25 (Page 20). Key investor presentation takeaways from Jubilant Ag

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Yasho Industries Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Yasho Industries Ltd Q3 FY26 results?

Yasho Industries aims to achieve approximately INR 1,500 crores revenue by FY '28 at around 40% utilization of Pakhajan facility capacity. Yasho Industries targets revenue of approx.

What is Yasho Industries Ltd share price analysis?

Yasho Industries Ltd currently shows a neutral. The stock trades at a P/E of 95.8 with a market cap of ₹5,013 Cr. Investors should review the full earnings analysis for detailed insights.

Is Yasho Industries Ltd planning capital expenditure?

Current year FY '26 capex is around INR 60 crores, including INR 25 crores for two new manufacturing lines and INR 25 crores for R&D. - Equipment deliveries for a strategic manufacturing project with a large MNC (cost approx.

Keep Yasho Industries Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.